Source-grounded facts extracted from Mosaic ImmunoEngineering Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Carlton Johnson resigned as Director at Mosaic ImmunoEngineering Inc..
“On July 23, 2024, Mr. Carlton Johnson notified the Board of Directors (the “Board”) of Mosaic ImmunoEngineering, Inc. (the “Company”) of his resignation from the Board effective immediately.”
Paul Lytle changed role as EVP, Chief Financial Officer at Mosaic ImmunoEngineering Inc..
“Mr. Paul Lytle, EVP, Chief Financial Officer of the Company, agreed to amend Mr. Lytle’s employment terms from full time status to part time status, not to exceed eight (8) hours per month effective June 1, 2024”
Gloria Felcyn departed as Director at Mosaic ImmunoEngineering Inc..
“Mosaic ImmunoEngineering, Inc. (the “Company”) is deeply saddened to announce that director Ms. Gloria Felcyn passed away on April 17, 2024.”
Mosaic ImmunoEngineering Inc. terminated License Agreement with Case Western Reserve University (effective 2024-03-22).
“on March 22, 2024, the Company received a letter of termination from CWRU terminating our Agreement effective immediately due to our financial default”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.